VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SORA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SORAAsiaStrategy
$1.75$44M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

SORA logoAsiaStrategy(SORA)Earnings, Financials & Key Ratios

SORA•NASDAQ
$1.75
27.2× P/E·Price updated Jul 6, 2026
SectorConsumer CyclicalIndustryFootwear & AccessoriesSub-IndustryFashion and luxury accessories brands
AboutAsiaStrategy, together with its subsidiaries, engages in trading, distribution, and retail of luxury watches in Hong Kong. The company sells its products under the Omega, Cartier, Rolex, Longines, Audermars Piguet, Patek Philippe, Blancpain, Casio, Breguet, and Hublot brands. It serves business-to-business (B2B) customers including distributors, independent watch dealers, and retail sellers. AsiaStrategy was formerly known as Top Win International Limited and changed its name to AsiaStrategy in August 2025. The company was founded in 2001 and is based in Wan Chai, Hong Kong. AsiaStrategy is a subsidiary of Pride River Limited.Show more
  • Revenue$1M-92.0%
  • EBITDA-$190K-182.6%
  • Net Income$2M+3835.1%
  • EPS (Diluted)0.06+3315.0%
  • Gross Margin2.58%-67.9%
  • EBITDA Margin-13.46%-1132.6%
  • Operating Margin-14.35%-1206.8%
  • Net Margin111.91%+46807.6%
  • ROE75.56%+799.5%

SORA Price & Volume

AsiaStrategy (SORA) stock price & volume — 10-year historical chart

Loading chart...

Structural Revenue Contraction Masks Deep Liquidity Risks

Investment Thesis • Updated 2024Q4

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Deteriorating
Primary Risk:Core business model collapse

Key Thesis Takeaways

  • AsiaStrategy faces a fundamental business model collapse as its transition to an opportunistic trading desk has resulted in a severe revenue contraction and structural margin weakness.
  • The company's reliance on non-operational accounting adjustments to mask underlying losses suggests significant insolvency risk despite recent balance sheet fluctuations.
  • Investors should remain cautious as the firm's inability to generate consistent operating cash flow, evidenced by a -8.60 OCF/NI ratio, threatens its long-term viability.

Verdict Logic

the company's valuation at 35.82x P/S is fundamentally unsupported by its negative operating cash flow and the extreme volatility in its working capital management.

SORA Growth Metrics

AsiaStrategy (SORA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-53.73%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years179.8%
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years180.93%
TTM-

Return on Capital

10 Years6.85%
5 Years6.85%
3 Years6.83%
Last Year-4.46%

Peers Comparison

Key metrics vs top competitors for AsiaStrategy (SORA)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
SORA logoSORAAsiaStrategyCurrent
$1.75$43.51M27.22-92%111.91%75.56%—
CAN logoCANCanaan Inc.
$0.29$184M-0.6496.69%-39.68%-60.72%—
CLPS logoCLPSCLPS Incorporation
$0.89$26.37M-3.4115.17%-3.05%-15.02%—
HUYA logoHUYAHUYA Inc.
$2.41$551.66M-34.106.96%-2.51%-2.41%—
IQ logoIQiQIYI, Inc.
$1.07$1.03B-34.60-6.62%-0.77%-0.22%—
DOYU logoDOYUDouYu International Holdings Limited
$4.81$145.16M-35.90-10.58%-4.81%-6.48%—

Compare SORA vs Peers

AsiaStrategy (SORA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CAN

Most directly comparable listed peer for SORA.

Scale Benchmark

vs BABA

Larger-name benchmark to compare SORA against a more recognizable public peer.

Peer Set

Compare Top 5

vs CAN, CLPS, HUYA, IQ

Get notified when SORA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SORA Frequently Asked Questions

AsiaStrategy (SORA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is AsiaStrategy's revenue?

AsiaStrategy (SORA) reported $1.4M in revenue for fiscal year 2025. This represents a 90% decrease from $14.2M in 2022.

How fast is AsiaStrategy growing?

AsiaStrategy (SORA) saw revenue decline by 92.0% over the past year.

Is SORA profitable?

Yes, AsiaStrategy (SORA) is profitable, generating $1.6M in net income for fiscal year 2025 (111.9% net margin).

Dividend & Returns
What is SORA's return on equity?

AsiaStrategy (SORA) has a return on equity (ROE) of 75.6%. This is excellent, indicating efficient use of shareholder capital.

What is AsiaStrategy's free cash flow?

AsiaStrategy (SORA) had negative free cash flow of $0.6M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in SORA back in 2022?

Total return calculator · dividends reinvested · 4+ years of data

See returns →